Literature DB >> 12352518

Fat laden macrophages in tracheal aspirates as a marker of reflux aspiration: a negative report.

Usha Krishnan1, John D Mitchell, Vivian Tobias, Andrew S Day, Timothy D Bohane.   

Abstract

OBJECTIVES: Refluxed gastric material aspirated into the lungs is an important cause of acute and chronic pulmonary disease. Currently, the presence of fat-laden macrophages (FLM) in tracheobronchial secretions of children is a conventional marker for reflux aspiration. However, this assay is limited by its apparent lack of specificity. The aim of this study was to reevaluate the role of this assay in diagnosing reflux aspiration.
METHODS: The tracheal aspirates of sixty-four consecutive children with clinically significant gastroesophageal reflux undergoing upper gastrointestinal endoscopy under general anesthesia, and 34 other children from the routine operative schedule were evaluated. Both groups were further subdivided on the basis of presence or absence of associated respiratory symptoms. After intubation, tracheal aspirates were collected, fixed, and stained for FLM. By grading the amount of intracellular fat present, a semiquantitative lipid index was computed. Tracheal aspirates with a lipid index of 100 or greater were considered positive.
RESULTS: Twenty-four of the 64 children with reflux symptoms and 14 of 34 children without reflux symptoms were positive for FLM. Sixteen of 37 children with both gastroesophageal reflux and respiratory symptoms and 10 of 26 children negative for both tested positive for FLM. The mean lipid index of the subgroup of children with both reflux and respiratory symptoms was not significantly different from that of the subgroup that was negative for both conditions. Despite computing a semiquantitative lipid index, an index of 100 or greater only had a sensitivity of 38% and specificity of 59%.
CONCLUSION: Assay of FLM in the tracheal aspirates of children considered at risk of reflux aspiration is not a sensitive or specific as a marker for reflux aspiration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352518     DOI: 10.1097/00005176-200209000-00013

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux.

Authors:  R Rosen; N Johnston; K Hart; U Khatwa; S Nurko
Journal:  Neurogastroenterol Motil       Date:  2011-12-05       Impact factor: 3.598

Review 2.  Biomarkers in the diagnosis of aspiration syndromes.

Authors:  Philippe Abou Jaoude; Paul R Knight; Patricia Ohtake; Ali A El-Solh
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

3.  Treatment options in pediatric GERD.

Authors:  Neelesh A Tipnis; Colin D Rudolph
Journal:  Curr Treat Options Gastroenterol       Date:  2007-10

4.  Lipid-laden macrophage index is not an indicator of gastroesophageal reflux-related respiratory disease in children.

Authors:  Rachel Rosen; Julia Fritz; Ariela Nurko; Dawn Simon; Samuel Nurko
Journal:  Pediatrics       Date:  2008-03-24       Impact factor: 7.124

5.  Positive bronchoalveolar lavage pepsin assay associated with viral and fungal respiratory infections in children with chronic cough.

Authors:  Corey N Martin; Zhour Barnawi; Elizabeth Chorvinsky; Dhruv Pillai; Meagan Gatti; Maura E Collins; Gina M Krakovsky; Nancy M Bauman; Sona Sehgal; Dinesh K Pillai
Journal:  Pediatr Pulmonol       Date:  2021-05-13

6.  Airway cellularity, lipid laden macrophages and microbiology of gastric juice and airways in children with reflux oesophagitis.

Authors:  A B Chang; N C Cox; J Purcell; J M Marchant; P J Lewindon; G J Cleghorn; L C Ee; G D Withers; M K Patrick; J Faoagali
Journal:  Respir Res       Date:  2005-07-15

7.  Clinical Utility of Bronchoalveolar Lavage Pepsin in Diagnosis of Gastroesophageal Reflux among Wheezy Infants.

Authors:  Ahmed Fathi Abdallah; Tarek El-Desoky; Khalid Fathi; Wagdy Fawzi Elkashef; Ahmed Zaki
Journal:  Can Respir J       Date:  2016-07-19       Impact factor: 2.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.